Comparison Between Modified Extracellular-Type Trehalose-Containing Kyoto Solution and University of Wisconsin Solution in 18-Hour Pancreas Preservation for Islet Transplantation

Pancreas. 2018 Aug;47(7):e46-e47. doi: 10.1097/MPA.0000000000001104.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Adenosine / pharmacology
  • Allopurinol / pharmacology
  • Animals
  • Blood Glucose / metabolism
  • Bucladesine / pharmacology
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / surgery
  • Female
  • Gluconates / pharmacology
  • Glutathione / pharmacology
  • Hydroxyethyl Starch Derivatives / pharmacology
  • Insulin / pharmacology
  • Islets of Langerhans Transplantation / methods*
  • Mice, Nude
  • Nitroglycerin / pharmacology
  • Organ Preservation / methods*
  • Organ Preservation Solutions / pharmacology*
  • Organ Preservation Solutions / standards
  • Pancreas / drug effects*
  • Raffinose / pharmacology
  • Reproducibility of Results
  • Swine
  • Transplantation, Heterologous
  • Trehalose / pharmacology

Substances

  • Blood Glucose
  • Gluconates
  • Hydroxyethyl Starch Derivatives
  • Insulin
  • Organ Preservation Solutions
  • University of Wisconsin-lactobionate solution
  • modified ET-Kyoto solution
  • Allopurinol
  • Bucladesine
  • Trehalose
  • Nitroglycerin
  • Glutathione
  • Adenosine
  • Raffinose
  • Acetylcysteine